RJA
DERM

Raymond James & Associates’s Dermira, Inc. DERM Stock Holding History

Raymond James & Associates’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-67,835
Closed -$1.83M – 3578
2017
Q3 		$1.83M Buy
67,835
+11,135
+20% +$291K ﹤0.01% 1706
2017
Q2 		$1.65M Buy
56,700
+489
+0.9% +$14.9K ﹤0.01% 1708
2017
Q1 		$1.92M Sell
56,211
-1,932
-3% -$62.3K ﹤0.01% 1554
2016
Q4 		$1.76M Sell
58,143
-1,713
-3% -$55.2K ﹤0.01% 1567
2016
Q3 		$2.02M Buy
59,856
+5,171
+9% +$167K 0.01% 1445
2016
Q2 		$1.6M Buy
+54,685
New +$1.51M 0.01% 1455

Other funds holding DERM

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Raymond James & Associates's DERM Position: Q4 2017 in Review

Raymond James & Associates sold out of Dermira, Inc. (DERM) in Q4 2017, closing a stake of 67,835 shares — an estimated $1.83M sold.

Raymond James & Associates first reported a position in DERM in Q2 2016 and held it in 6 quarters. The position peaked at $2.02M in Q3 2016. 126 funds tracked by Wall St. Rank hold DERM as of Q4 2017.

  • Raymond James & Associates reported no remaining Dermira, Inc. position as of Q4 2017 after selling out during the quarter.
  • Raymond James & Associates sold 67,835 Dermira, Inc. shares in Q4 2017, an estimated $1.83M.
  • Raymond James & Associates first reported a position in Dermira, Inc. in Q2 2016 and held it in 6 quarters.
  • Raymond James & Associates's Dermira, Inc. position peaked at $2.02M in Q3 2016.
  • 126 funds tracked by Wall St. Rank held Dermira, Inc. as of Q4 2017.

Based on Raymond James & Associates's 13F filing for Q4 2017, filed 14 Feb 2018.